Does the media refer more to CAI or CDNA?

In the previous week, CareDx had 4 more articles in the media than Caris Life Sciences. MarketBeat recorded 6 mentions for CareDx and 2 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.89 beat CareDx's score of 0.70 indicating that Caris Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive CareDx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, CDNA or BLLN?

Billiontoone has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareDx $379.80M 3.88 -$21.35M -$0.16 N/A Billiontoone $305.11M 18.02 $7.45M $0.55 217.35

Does the media prefer CDNA or BLLN?

In the previous week, CareDx had 1 more articles in the media than Billiontoone. MarketBeat recorded 6 mentions for CareDx and 5 mentions for Billiontoone. CareDx's average media sentiment score of 0.70 beat Billiontoone's score of 0.48 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Billiontoone 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, SHC or CDNA?

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.35 $77.94M $0.41 43.29 CareDx $379.80M 3.88 -$21.35M -$0.16 N/A

Is SHC or CDNA more profitable?

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets Sotera Health 9.91% 39.73% 7.05% CareDx -2.01% -2.65% -1.96%

Does the media refer more to SHC or CDNA?

In the previous week, CareDx had 3 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for CareDx and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.94 beat CareDx's score of 0.70 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, CELC or CDNA?

CareDx has higher revenue and earnings than Celcuity. CareDx is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Celcuity N/A N/A -$177.04M -$3.90 N/A CareDx $379.80M 3.88 -$21.35M -$0.16 N/A

Is CELC or CDNA more profitable?

Celcuity has a net margin of 0.00% compared to CareDx's net margin of -2.01%. CareDx's return on equity of -2.65% beat Celcuity's return on equity. Company Net Margins Return on Equity Return on Assets Celcuity N/A -244.61% -50.22% CareDx -2.01% -2.65% -1.96%

Does the media refer more to CELC or CDNA?

In the previous week, CareDx had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for CareDx and 3 mentions for Celcuity. CareDx's average media sentiment score of 0.70 beat Celcuity's score of 0.62 indicating that CareDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CareDx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, CDNA or VCYT?

Veracyte has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareDx $379.80M 3.88 -$21.35M -$0.16 N/A Veracyte $517.15M 9.06 $66.35M $1.09 53.88

Is CDNA or VCYT more profitable?

Veracyte has a net margin of 16.25% compared to CareDx's net margin of -2.01%. Veracyte's return on equity of 9.07% beat CareDx's return on equity. Company Net Margins Return on Equity Return on Assets CareDx -2.01% -2.65% -1.96% Veracyte 16.25% 9.07% 8.38%

Does the media prefer CDNA or VCYT?

In the previous week, CareDx and CareDx both had 6 articles in the media. CareDx's average media sentiment score of 0.70 beat Veracyte's score of 0.67 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Veracyte 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

CareDx (CDNA) Competitors

$28.50 -0.78 (-2.66%)

Closing price 06/30/2026 04:00 PM Eastern

Extended Trading

$28.48 -0.02 (-0.09%)

As of 06/30/2026 07:12 PM Eastern

Compare

CDNA vs. CAI, BLLN, SHC, CELC, and VCYT

Should you buy CareDx stock or one of its competitors? MarketBeat compares CareDx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareDx include Caris Life Sciences (CAI), Billiontoone (BLLN), Sotera Health (SHC), Celcuity (CELC), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does CareDx compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and CareDx (NASDAQ:CDNA) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

Caris Life Sciences has a net margin of 3.75% compared to CareDx's net margin of -2.01%. Caris Life Sciences' return on equity of 98.28% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
CareDx	-2.01%	-2.65%	-1.96%

Caris Life Sciences currently has a consensus price target of $27.56, indicating a potential upside of 54.40%. CareDx has a consensus price target of $25.00, indicating a potential downside of 12.28%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, research analysts plainly believe Caris Life Sciences is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

CareDx has lower revenue, but higher earnings than Caris Life Sciences. CareDx is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.21	-$68.09M	-$7.61	N/A
CareDx	$379.80M	3.88	-$21.35M	-$0.16	N/A

In the previous week, CareDx had 4 more articles in the media than Caris Life Sciences. MarketBeat recorded 6 mentions for CareDx and 2 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.89 beat CareDx's score of 0.70 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
CareDx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Caris Life Sciences beats CareDx on 10 of the 13 factors compared between the two stocks.

How does CareDx compare to Billiontoone?

CareDx (NASDAQ:CDNA) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

CareDx currently has a consensus target price of $25.00, suggesting a potential downside of 12.28%. Billiontoone has a consensus target price of $126.00, suggesting a potential upside of 5.40%. Given Billiontoone's stronger consensus rating and higher probable upside, analysts plainly believe Billiontoone is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	3.88	-$21.35M	-$0.16	N/A
Billiontoone	$305.11M	18.02	$7.45M	$0.55	217.35

In the previous week, CareDx had 1 more articles in the media than Billiontoone. MarketBeat recorded 6 mentions for CareDx and 5 mentions for Billiontoone. CareDx's average media sentiment score of 0.70 beat Billiontoone's score of 0.48 indicating that CareDx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Billiontoone	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Billiontoone has a net margin of 0.00% compared to CareDx's net margin of -2.01%. Billiontoone's return on equity of 0.00% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Billiontoone	N/A	N/A	N/A

Summary

Billiontoone beats CareDx on 10 of the 13 factors compared between the two stocks.

How does CareDx compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
CareDx	-2.01%	-2.65%	-1.96%

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 2.4% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.35	$77.94M	$0.41	43.29
CareDx	$379.80M	3.88	-$21.35M	-$0.16	N/A

In the previous week, CareDx had 3 more articles in the media than Sotera Health. MarketBeat recorded 6 mentions for CareDx and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 0.94 beat CareDx's score of 0.70 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareDx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Sotera Health presently has a consensus price target of $20.25, indicating a potential upside of 14.08%. CareDx has a consensus price target of $25.00, indicating a potential downside of 12.28%. Given Sotera Health's stronger consensus rating and higher probable upside, analysts plainly believe Sotera Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Sotera Health has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, CareDx has a beta of 2.49, suggesting that its stock price is 149% more volatile than the broader market.

Summary

Sotera Health beats CareDx on 14 of the 16 factors compared between the two stocks.

How does CareDx compare to Celcuity?

Celcuity (NASDAQ:CELC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

CareDx has higher revenue and earnings than Celcuity. CareDx is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
CareDx	$379.80M	3.88	-$21.35M	-$0.16	N/A

63.3% of Celcuity shares are owned by institutional investors. 13.3% of Celcuity shares are owned by insiders. Comparatively, 2.4% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Celcuity has a net margin of 0.00% compared to CareDx's net margin of -2.01%. CareDx's return on equity of -2.65% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
CareDx	-2.01%	-2.65%	-1.96%

Celcuity currently has a consensus target price of $152.09, indicating a potential upside of 45.37%. CareDx has a consensus target price of $25.00, indicating a potential downside of 12.28%. Given Celcuity's stronger consensus rating and higher probable upside, equities analysts clearly believe Celcuity is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Celcuity has a beta of 0.1, suggesting that its share price is 90% less volatile than the broader market. Comparatively, CareDx has a beta of 2.49, suggesting that its share price is 149% more volatile than the broader market.

In the previous week, CareDx had 3 more articles in the media than Celcuity. MarketBeat recorded 6 mentions for CareDx and 3 mentions for Celcuity. CareDx's average media sentiment score of 0.70 beat Celcuity's score of 0.62 indicating that CareDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CareDx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CareDx beats Celcuity on 8 of the 15 factors compared between the two stocks.

How does CareDx compare to Veracyte?

CareDx (NASDAQ:CDNA) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, risk and profitability.

CareDx has a beta of 2.49, suggesting that its share price is 149% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.98, suggesting that its share price is 98% more volatile than the broader market.

Veracyte has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	3.88	-$21.35M	-$0.16	N/A
Veracyte	$517.15M	9.06	$66.35M	$1.09	53.88

In the previous week, CareDx and CareDx both had 6 articles in the media. CareDx's average media sentiment score of 0.70 beat Veracyte's score of 0.67 indicating that CareDx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareDx	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Veracyte	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

CareDx currently has a consensus target price of $25.00, suggesting a potential downside of 12.28%. Veracyte has a consensus target price of $50.43, suggesting a potential downside of 14.13%. Given CareDx's higher probable upside, equities analysts plainly believe CareDx is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56

Veracyte has a net margin of 16.25% compared to CareDx's net margin of -2.01%. Veracyte's return on equity of 9.07% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Veracyte	16.25%	9.07%	8.38%

Summary

Veracyte beats CareDx on 11 of the 14 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDNA vs. The Competition

Export

Metric	CareDx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.51B	$9.35B	$7.07B	$12.45B
Dividend Yield	N/A	1.66%	2.66%	6.16%
P/E Ratio	-178.13	26.17	27.51	24.87
Price / Sales	3.88	17.10	540.69	102.84
Price / Cash	4,495.35	114.51	48.53	58.59
Price / Book	4.84	5.95	11.01	6.54
Net Income	-$21.35M	$179.69M	$3.57B	$336.70M
7 Day Performance	5.05%	2.38%	2.31%	2.88%
1 Month Performance	25.00%	5.27%	1.38%	0.64%
1 Year Performance	51.19%	12.22%	36.70%	31.34%

CareDx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CDNA CareDx	1.2495 of 5 stars	$28.50 -2.7%	$25.00 -12.3%	+45.9%	$1.51B	$379.80M	N/A	740	Insider Trade
CAI Caris Life Sciences	4.229 of 5 stars	$17.31 -6.3%	$27.56 +59.2%	N/A	$5.22B	$348.89M	N/A	1,846	Positive News
BLLN Billiontoone	2.8282 of 5 stars	$100.72 -4.2%	$125.29 +24.4%	N/A	$4.84B	$354.54M	183.13	620	Analyst Forecast
SHC Sotera Health	3.5081 of 5 stars	$15.74 -0.5%	$20.29 +28.9%	+59.6%	$4.51B	$1.16B	38.39	3,000
CELC Celcuity	3.468 of 5 stars	$89.93 +2.5%	$152.09 +69.1%	+683.7%	$4.28B	N/A	N/A	40

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDNA) was last updated on 7/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareDx (CDNA) Competitors

CDNA vs. CAI, BLLN, SHC, CELC, and VCYT

How does CareDx compare to Caris Life Sciences?

Summary

How does CareDx compare to Billiontoone?

Summary

How does CareDx compare to Sotera Health?

Summary

How does CareDx compare to Celcuity?

Summary

How does CareDx compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDNA vs. The Competition

CareDx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareDx (CDNA) Competitors

CDNA vs. CAI, BLLN, SHC, CELC, and VCYT

How does CareDx compare to Caris Life Sciences?

Is CAI or CDNA more profitable?

Do analysts rate CAI or CDNA?

Which has better earnings and valuation, CAI or CDNA?

Does the media refer more to CAI or CDNA?

Summary

How does CareDx compare to Billiontoone?

Do analysts prefer CDNA or BLLN?

Which has better valuation & earnings, CDNA or BLLN?

Does the media prefer CDNA or BLLN?

Is CDNA or BLLN more profitable?

Summary

How does CareDx compare to Sotera Health?

Is SHC or CDNA more profitable?

Do institutionals and insiders believe in SHC or CDNA?

Which has preferable valuation and earnings, SHC or CDNA?

Does the media refer more to SHC or CDNA?

Do analysts rate SHC or CDNA?

Which has more risk and volatility, SHC or CDNA?

Summary

How does CareDx compare to Celcuity?

Which has stronger earnings & valuation, CELC or CDNA?

Do insiders and institutionals believe in CELC or CDNA?

Is CELC or CDNA more profitable?

Do analysts recommend CELC or CDNA?

Which has more volatility and risk, CELC or CDNA?

Does the media refer more to CELC or CDNA?

Summary

How does CareDx compare to Veracyte?

Which has more volatility and risk, CDNA or VCYT?

Which has stronger valuation and earnings, CDNA or VCYT?

Does the media prefer CDNA or VCYT?

Do analysts recommend CDNA or VCYT?

Is CDNA or VCYT more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDNA vs. The Competition

CareDx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools